February 11, 2013 - Biolase, a medical device manufacturer based in Irvine, California, announced that it had received approval from the United States Food and Drug Administration (FDA) for its 940 nm Diolase 10 laser. In addition, the company announced that the FDA had granted approval for use of the device in additional 80 procedures.

In its press release, the dental laser company stated that its products are now available in over 20 different markets. The company’s laser technology can be used for plastic surgery, ophthalmology, dermatology and arthroscopy.

According to Biolase, the Diolase 10 is designed for use as an alternative to traditional dental drills. The device uses a specialized 940 nm wavelength that makes it ideal for pain relief and tooth whitening.

In October of 2012, the company also won approval for the Epic 10 diode. The Epic 10 system is a specialized module that controls the power level of a laser beam.

Fred Furry is the chief financial officer at Biolase. In prepared remarks, he said, "We will use the clearances received for the Diolase 10, now established as a 940 nm diode laser predicate device, to obtain the same clearances for our Epic 10 platform, which uses the same wavelength.”

References

http://phx.corporate-ir.net/phoenix.zhtml?c=69766&p=irol-news&nyo=0